Polydex Pharmaceuticals (POLXF) Short Interest Ratio & Short Volume

Short interest is the volume of Polydex Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 100 shares of POLXF short. Learn More on Polydex Pharmaceuticals' current short interest.

Polydex Pharmaceuticals saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Polydex Pharmaceuticals: Creative Medical Technology Holdings, Inc. (2.17%), Cadrenal Therapeutics, Inc. (0.50%), Calidi Biotherapeutics, Inc. (0.42%), AquaBounty Technologies, Inc. (4.27%), Syra Health Corp. (2.52%), Mangoceuticals, Inc. (5.27%), eFFECTOR Therapeutics, Inc. (10.72%), Heart Test Laboratories, Inc. (0.31%), Fuse Medical, Inc. (0.01%), Sonendo, Inc. (0.68%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks.

Short selling POLXF is an investing strategy that aims to generate trading profit from Polydex Pharmaceuticals as its price is falling. POLXF shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Polydex Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of POLXF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including POLXF, twice per month. The most recent reporting period available is July, 31 2023.